Brimonidine Ophthalmic Solution [Alphagan]
RxNorm 363786
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 363786 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: brimonidine Ophthalmic Solution [Alphagan].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDFPrescribable
Semantic Branded Drug Form (SBDF):
Brimonidine Ophthalmic Solution [Alphagan]
(Atom ID: 2052625)
Patient Education
Brimonidine Ophthalmic
Ophthalmic brimonidine is used to lower pressure in the eyes in patients who have glaucoma (high pressure in the eyes that may damage nerves and cause vision loss) and ocular hypertension (pressure in the eyes that is higher than normal but not high enough to cause vision loss). Brimonidine is in a class of drugs called alpha adrenergic agonists. Brimonidine works by decreasing the amount of fluid in the eyes.
[Learn More]
* Please review the disclaimer below.